New York, NY (PRWEB) December 11, 2006
Scientific American's science news web site, sciam.com, today posted 10 health news Clinical Trials to watch closely for their potentially significant impact on health and wellness. The trials cited by sciam.com are currently in progress in the United States and other countries around the world. For detailed information pertaining to all of the clinical trials, science news, and their sponsors, visit sciam.com.
A clinical trial is an investigative research study in human volunteers to address and answer specific health questions. There are five classifications of clinical trials: treatment, prevention, diagnostic, screening and quality of life. Every clinical trial follows a protocol regiment; a carefully prescribed plan that occurs over an allocated time period. A protocol identifies the types of patients who may enter the study, the schedule of tests, procedures, drugs and dosages as well as how the outcomes will be measured. Each participant will be observed and monitored carefully and must comply with the rules as defined in the protocol. Scientists report their findings to the medical community and various government agencies during three distinct phases of the clinical trial process. All of the trials on sciam.com's list are either in Phase II or Phase III.
The 10 Clinical Trials announced on sciam.com cover health news research relevant to the following diseases and disorders:
Vision loss from macular degeneration
About Scientific American
Scientific American.com (sciam.com), which debuted in 1996, has grown into a dynamic online science news resource that provides coverage of the latest in science and technology as well as articles from current and past issues, podcasts, website exclusives, daily science news, blogs and weekly polls. It has become a leading online science and technology destination with more than 1,700,000 visitors per month.
For more than 155 years, Scientific American, one of the world's most enduring and revered science and technology magazines, has chronicled for its readers major and technology innovations and discoveries using expert accounts and assorted journalistic features. The magazine publishes 15 foreign language editions with a total circulation of more than 1,000,000 worldwide.